DIABELOOP
Diabeloop is a medical device company for diabetes and closed-loop system. It also develops disruptive technological innovations to automate the treatment of diabetes. The company mission is to make accessible disruptive technological innovations that will allow people with type 1 diabetes to live the life they want. Diabeloop was founded in 2015 and is headquartered in Grenoble, Auvergne-Rhône-Alpes, France.
DIABELOOP
Industry:
Clinical Trials Health Care Medical Medical Device
Founded:
2015-03-03
Address:
Grenoble, Rhone-Alpes, France
Country:
France
Website Url:
http://www.diabeloop.fr
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
128.99 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Apple Mobile Web Clips Icon Google Tag Manager WordPress Font Awesome Nginx Sitelinks Search Box Yoast WordPress SEO Plugin
Similar Organizations
Diamedico FAIRsand
Diamedico FAIRsand is a mail-order company for diabetic needs.
Genetron Health
Genetron Health is a world-leading expert in precision medicine.
Sensome
Sensome offers micro-sensor technology to turn medical devices into connected healthcare devices.
MediPrint Ophthalmics
MediPrint Ophthalmics is a clinical stage eye care pharmaceutical company.
Minerva Surgical
Minerva Surgical is a medical device start-up company developing medical devices for women’s healthcare.
Qihan Biotech
Qihan Biotech is a gene-editing organ transplantation technology developer.
Route 92 Medical
Route 92 Medical is a medical device company developing a catheter to treat stroke.
Stel Life
Stel Life simplifies health device connectivity for patients, care teams, and device companies.
Turn Medical
Turn Medical is a medical device company delivering healthcare solutions from patients to clinicians.
Current Advisors List
Current Employees Featured
Founder
Investors List
Innovacom
Innovacom investment in Series C - Diabeloop
Terumo Corporation
Terumo Corporation investment in Series C - Diabeloop
Cemag Invest
Cemag Invest investment in Series C - Diabeloop
Promontoires
Promontoires investment in Series C - Diabeloop
KREAXI
KREAXI investment in Series C - Diabeloop
Crédit Agricole
Crédit Agricole investment in Series C - Diabeloop
ODYSSEE VENTURE
ODYSSEE VENTURE investment in Series C - Diabeloop
Bpifrance
Bpifrance investment in Debt Financing - Diabeloop
LBO France
LBO France investment in Series C - Diabeloop
UI Investissement
UI Investissement investment in Series C - Diabeloop
Newest Events participated
Official Site Inspections
http://www.diabeloop.fr Semrush global rank: 244.14 K Semrush visits lastest month: 287.4 K
- Host name: ec2-54-72-117-41.eu-west-1.compute.amazonaws.com
- IP address: 54.72.117.41
- Location: Dublin Ireland
- Latitude: 53.3338
- Longitude: -6.2488
- Timezone: Europe/Dublin
- Postal: D02
More informations about "Diabeloop"
Diabeloop automatise et personnalise le traitement du diabète de …
Jul 27, 2023 Pour que les passions rythment la vie. Pas le diabète ! Diabeloop, partenaire des patients : depuis sa création, Diabeloop implique les personnes avec un diabète de type 1 ou …See details»
Company | Diabeloop
Fr de es it nl Diabeloop, A Company Focused On Collective Intelligence ... managed by Dr. Guillaume Charpentier, is a non-profit organization dedicated to diabetes research and treatment. Medical Centers. Since 2010, Diabeloop has …See details»
Entreprise - Diabeloop
Site destiné aux résidents de France. Diabeloop, DBLG1, Rock Your Diabetes et YourLoops sont des marques déposées ou des marques enregistrées de Diabeloop SA en Europe et/ou dans d’autres pays. Dexcom et Dexcom G6, …See details»
Diabeloop - Crunchbase Company Profile & Funding
Diabeloop is a medical device company for diabetes and closed-loop system. It also develops disruptive technological innovations to automate the treatment of diabetes. The company mission is to make accessible disruptive technological …See details»
Diabeloop automates and personalizes the treatment of Type 1 …
Feb 17, 2023 Diabeloop developed a self-learning algorithm that embeds therapeutic artificial intelligence, to automate Type 1 diabetes treatment. It is intended to relieve people affected by …See details»
DIABELOOP - Societe.com
DIABELOOP, société anonyme à conseil d'administration, au capital social de 1696504,00 EURO, dont le siège social est situé au 17 RUE FELIX ESCLANGON, 38000 GRENOBLE, …See details»
Diabeloop Completes Record-Breaking European Fundraising …
Diabeloop announced today that it has completed a 31-million-euro Series B round of funding, setting a European fundraising record in the area of therapeutic artificial intelligence. This …See details»
dbl-diabète | Informations et actualités sur le diabète …
La mission de Diabeloop est de rendre l’innovation accessible aux personnes vivant avec un diabète, afin d’améliorer les résultats cliniques tout en les soulageant de leur charge mentale constante. Nos technologies s’appuient …See details»
An inside look at Diabeloop: the French startup …
Nov 5, 2019 France and Germany are priority markets, with France reimbursement modality had been filed while discussions are on-going for Germany. Diabeloop plans to extend this mode of acquisition of the DBLG1 …See details»
Le point sur Diabeloop : le pancréas artificiel … | Fédération ...
Aug 31, 2016 Diabeloop : un dispositif innovant. Diabeloop est un projet initié en 2011 par le CERITD (Centre d’Etude pour la Recherche et l’Intensification du Traitement du Diabète) et le …See details»
Diabeloop poursuit son développement : les bons résultats de la …
Sep 9, 2019 La première vise à évaluer l’intérêt de Diabeloop chez les enfants. Cette étude a débuté dans deux centres pédiatriques en France et sera poursuivie en Belgique. L’objectif est …See details»
Diabète : la medtech Diabeloop lève 70 millions d'euros
Jun 7, 2022 Diabète : la medtech Diabeloop lève 70 millions d'euros. Spécialisée en intelligence artificielle thérapeutique, la PME grenobloise développe un dispositif pour diabétiques …See details»
Significant improvement in increasing Time In Range and
EASD 2021 – Diabeloop, a pioneer in therapeutic artificial intelligence for diabetes management, is presenting new real-world data1 of its Automated Insulin Delivery system, DBLG1. The …See details»
Diabeloop | Solution de prise en charge du diabète (Avis)
Nov 4, 2024 Le système DBLG1 de Diabeloop représente une avancée significative dans la prise en charge du diabète de type 1. En tant que professionnels de santé, il est crucial de …See details»
Diabeloop shifts into high gear in France and around the globe
Dec 7, 2021 Diabeloop obtained French national health insurance approval for its DBLG1 closed-loop automated insulin therapy device (DBLG1) in September. Now the Grenoble s …See details»
Diabeloop accélère sa stratégie d’interopérabilité avec les stylos ...
SFD 2023 - Diabeloop, pionnière de la délivrance automatisée d'insuline, va collaborer avec Novo Nordisk, un leader international de la santé. L’accord porte sur l'intégration de DBL-4pen® - …See details»
Le système en boucle fermée hybride DBLG1 Diabeloop, enfin …
Sep 16, 2021 Attendu depuis des années, le dispositif en boucle fermée hybride, le système DBLG1 Diabeloop, sera enfin pris en charge par l’ Assurance Maladie à partir du 28 …See details»
Diabeloop introduces an automated management solution for …
DBL-hu, a medical device dedicated to the autonomous management of highly unstable diabetes 1, obtained its CE mark less than a year after the launch of its pivotal clinical trial began.. …See details»
BIOCORP and Diabeloop announce co-development agreement in …
Issoire, Grenoble, March 22, 2021, at 8:00 am CET – BIOCORP (FR0012788065 – ALCOR / Eligible PEA PME), a French company specialized in the development and manufacturing of …See details»
12 mois de vie avec la boucle fermée hybride de Diabeloop
EASD 2022 - Diabeloop, leader de l’IA thérapeutique appliquée à la délivrance d'insuline, annonce aujourd'hui des résultats sur 12 mois d'utilisation de sa boucle fermée, sur une large …See details»